Literature DB >> 20130465

Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival.

Alessandro Gronchi1, Salvatore Lo Vullo, Chiara Colombo, Paola Collini, Silvia Stacchiotti, Luigi Mariani, Marco Fiore, Paolo Giovanni Casali.   

Abstract

PURPOSE: To improve understanding of what is adequate in local treatment of extremity soft tissue sarcomas (ESTS), to maximize the ratio between local control, limb preservation and prognosis. PATIENT AND METHODS: Nine hundred ninety-seven consecutive patients affected by primary ESTS were reviewed. Size, depth, histotype and grade of the tumor, margin status (R0, R1, R2) of surgical resection, and adjuvant treatments were analyzed. Univariable and multivariable analysis were carried out. For the subgroup of R1 resection the presence/absence of the tumor at the inked surface and the presence/absence of an anatomic barrier were also considered.
RESULTS: Five- and 10-year mortality estimates (95% confidence interval) were 0.29 (0.20-0.38) and 0.38 (0.28-0.49) in R1 cases, and 0.16 (0.13-0.19) and 0.19 (0.16-0.23) in R0 cases (P = 0.0003). Size, grade, depth, and histologic subtype were also significant predictor of mortality. Significant determinants for local relapse were surgical margins, radiation therapy, and histologic subtype. In the subset of R1 resections trends towards a better local control for R1 negative cases and histology other than myxofibrosarcoma were identified. Significant determinants for distant metastases were size, grade and histologic subtype of the tumor but not surgical margins.
CONCLUSIONS: Quality of surgical margins independently predicted local control and survival. The effect on survival was directly mediated by local recurrence to proximal sites invading the abdomen/thorax, and this may indeed be the main way by which quality of surgery directly impacts the final prognosis of ESTS patients.

Entities:  

Mesh:

Year:  2010        PMID: 20130465     DOI: 10.1097/SLA.0b013e3181cf87fa

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  72 in total

1.  Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?

Authors:  Florian Posch; Lukas Leitner; Marko Bergovec; Angelika Bezan; Michael Stotz; Armin Gerger; Martin Pichler; Herbert Stöger; Bernadette Liegl-Atzwanger; Andreas Leithner; Joanna Szkandera
Journal:  Clin Orthop Relat Res       Date:  2017-01-12       Impact factor: 4.176

2.  A retrospective review of 145 patients with angiosarcoma: Radiation therapy, extent of resection and chemotherapy are important predictors of survival.

Authors:  Alannah Smrke; Jeremy Hamm; Anand Karvat; Christine Simmons; Amirrtha Srikanthan
Journal:  Mol Clin Oncol       Date:  2020-06-02

3.  Trends in presentation of bone and soft tissue sarcomas over 25 years: little evidence of earlier diagnosis.

Authors:  G M Smith; G D Johnson; R J Grimer; S Wilson
Journal:  Ann R Coll Surg Engl       Date:  2011-10       Impact factor: 1.891

4.  Prognostic Significance of Histological Subtype in Soft Tissue Sarcoma With Distant Metastasis.

Authors:  Hiroyuki Tsuchie; Makoto Emori; Naohisa Miyakoshi; Hiroyuki Nagasawa; Kyoji Okada; Yasutaka Murahashi; Emi Mizushima; Junya Shimizu; Toshihiko Yamashita; Yoichi Shimada
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

5.  Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy.

Authors:  Emily Z Keung; Jen-Wei Tsai; Ali M Ali; Janice N Cormier; Andrew J Bishop; B Ashleigh Guadagnolo; Keila E Torres; Neeta Somaiah; Kelly K Hunt; Jennifer A Wargo; Alexander J Lazar; Wei-Lien Wang; Christina L Roland
Journal:  Oncoimmunology       Date:  2017-10-31       Impact factor: 8.110

6.  Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It.

Authors:  Kamran Harati; Ole Goertz; Andreas Pieper; Adrien Daigeler; Hamid Joneidi-Jafari; Hiltrud Niggemann; Ingo Stricker; Marcus Lehnhardt
Journal:  Oncologist       Date:  2017-07-24

7.  Efficacy of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity: 20-year follow-up of a randomized prospective trial.

Authors:  Joal D Beane; James C Yang; Donald White; Seth M Steinberg; Steven A Rosenberg; Udo Rudloff
Journal:  Ann Surg Oncol       Date:  2014-04-23       Impact factor: 5.344

8.  CORR Insights®: Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?

Authors:  Lukas M Nystrom
Journal:  Clin Orthop Relat Res       Date:  2017-02-27       Impact factor: 4.176

9.  ''Two-week waits"-are they leading to earlier diagnosis of soft-tissue sarcomas?

Authors:  W St J Taylor; R J Grimer; S R Carter; R M Tillman; A Abudu; L Jeys
Journal:  Sarcoma       Date:  2010-09-26

10.  How long should we follow patients with soft tissue sarcomas?

Authors:  Chigusa Sawamura; Seiichi Matsumoto; Takashi Shimoji; Atsushi Okawa; Keisuke Ae
Journal:  Clin Orthop Relat Res       Date:  2014-03       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.